Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-12-07
1990-01-23
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546169, C07D21554, A61K 3147
Patent
active
048958565
ABSTRACT:
New original derivatives are described of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4-oxobutanoic acids having the formula: ##STR1## in which n is 1 or 2, R.sub.1 is selected from the groups 2-naphthyl, 2 (or 3)-quinolinyl, 2 (or 3)-indolyl, 2 (or 3)-benzofuranyl, 2 (or 3)-benzothiophenyl, and R.sub.2 is a pentyl group or an alkoxyalkyl group with 4 or 5 carbon atoms, preferably pentyl, 2-ethoxyethyl, 3-methoxypropyl or 3-ethoxypropyl.
The compounds have a powerful antagonistic activity towards cholecystokinin and are particularly useful in the treatment of illnesses of the digestive system, such as colitis, biliary diskinesia, pancreatitis or in the treatment of disorders of the central nervous system imputable to deficiencies in the physiological neuron levels of cholecystokinin or other related bioactive polypeptides.
REFERENCES:
patent: 4252957 (1981-02-01), Holland et al.
Chiste Rolando
Makovec Francesco
Peris Walter
Rovati Luigi
Northington-Davis Zinna
Rotta Research Laboratorium S.p.A.
Schwartz Richard A.
LandOfFree
Derivatives of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-645441